Has John Strother, MD received payments from drug or device companies?

Yes. Drug and device makers reported $639,671 in general payments to John Strother, MD across 345 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Strother, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Strother, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Strother, MD

Hematology & Oncology · Salem, ORNPI 1518922111

Payments from drug & device makers

$639,671in general payments, 2019–2025

Across 345 payments — averaging $1854.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$232K
GSK$168K
Janssen Research & Development, LLC$72K
Incyte Corporation$56K
Beone Medicines Ltd.$56K
Eli Lilly$31K
plus $24K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	11	$232,417
GSK	132	$168,307
Janssen Research & Development, LLC	53	$72,272
Incyte Corporation	21	$55,864
Beone Medicines Ltd.	4	$55,740
Eli Lilly	1	$31,003
Bristol Myers Squibb	9	$16,874
E.r. Squibb & Sons, L.L.C.	7	$4,724
Astellas Pharma US Inc	9	$310
Pfizer	10	$218
Novartis	13	$205
Beone Medicines USA, Inc.	5	$202
Biontech SE	2	$184
AstraZeneca(2 entities)	8	$162
Johnson & Johnson	7	$151
Amgen	5	$129
Sanofi	4	$94
AbbVie	4	$84
Jazz Pharmaceuticals Inc.	3	$76
Lilly USA, LLC	4	$68
Gilead(2 entities)	4	$66
Seagen Inc.	3	$53
AVEO Pharmaceuticals, Inc.	2	$35
Regeneron Healthcare Solutions, Inc.	1	$32
Taiho Oncology, Inc.	2	$28
Takeda Pharmaceuticals U.S.A., Inc.	2	$28
Sumitomo Pharma America, Inc.	1	$27
Myovant Sciences Inc.	1	$24
Kyowa Kirin, Inc.	1	$22
Springworks Therapeutics, Inc.	1	$21
Genentech USA, Inc.	1	$21
Verity Pharmaceuticals Inc.	1	$21
Clovis Oncology, Inc.	1	$19
Tesaro, Inc.	1	$19
Tersera Therapeutics LLC	1	$19
Eisai Inc.	1	$18
Helsinn Therapeutics (U.S.), Inc.	1	$17
Agios Pharmaceuticals, Inc.	1	$17
Ipsen Biopharmaceuticals, Inc	1	$16
Acrotech Biopharma Inc.	1	$16
Octapharma USA, Inc.	1	$16
Lexicon Pharmaceuticals, Inc.	1	$15
Bayer	1	$14
EMD Serono, Inc.	1	$14
Aurobindo Pharma USA, Inc.	1	$13

How this compares

$639,671 in reported general payments places this provider in the 75th percentile of 112 hematology & oncology providers in Oregon.

See all hematology & oncology providers in Oregon →

Medicare billing

Part B allowed, 2024

$3,206,437

Medicare patients

631

Services billed

134,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Salem

Janelle MeyerSalem$1.6M
William PierceSalem$9K
Michael HeinrichPortland$25M
Jay AndersenPortland$8.3M
Elie TraerPortland$6.5M
Ian SchnadigTualatin$6.4M
Jacqueline VukyPortland$5.4M
Sandeep MashruPortland$4.6M
Abdul Hai MansoorPortland$3.5M
Aimee KohnPortland$3.3M

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →